These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17437163)

  • 1. Influence of methotrexate dose on its efficacy and safety in rheumatoid arthritis patients: evidence based on the variety of prescribing approaches among practicing Japanese rheumatologists in a single institute-based large observational cohort (IORRA).
    Yamanaka H; Inoue E; Tanaka E; Nakajima A; Taniguchi A; Terai C; Hara M; Tomatsu T; Kamatani N
    Mod Rheumatol; 2007; 17(2):98-105. PubMed ID: 17437163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of disease activity of rheumatoid arthritis patients from 2000 to 2006 in a large observational cohort study IORRA in Japan.
    Yamanaka H; Inoue E; Singh G; Tanaka E; Nakajima A; Taniguchi A; Hara M; Tomatsu T; Kamatani N
    Mod Rheumatol; 2007; 17(4):283-9. PubMed ID: 17694260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the efficacy and safety of methotrexate at dosages over 8 mg/week using the IORRA cohort database.
    Seto Y; Tanaka E; Inoue E; Nakajima A; Taniguchi A; Momohara S; Yamanaka H
    Mod Rheumatol; 2011 Dec; 21(6):579-93. PubMed ID: 21424533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial comparing 2 different starting doses of methotrexate in rheumatoid arthritis.
    Dhir V; Singla M; Gupta N; Goyal P; Sagar V; Sharma A; Khanna S; Singh S
    Clin Ther; 2014 Jul; 36(7):1005-15. PubMed ID: 24976447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
    Müller RB; von Kempis J; Haile SR; Schiff MH
    Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA.
    Shidara K; Hoshi D; Inoue E; Yamada T; Nakajima A; Taniguchi A; Hara M; Momohara S; Kamatani N; Yamanaka H
    Mod Rheumatol; 2010 Jun; 20(3):280-6. PubMed ID: 20217173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.
    Tanaka E; Mannalithara A; Inoue E; Hara M; Tomatsu T; Kamatani N; Singh G; Yamanaka H
    Ann Rheum Dis; 2008 Aug; 67(8):1153-8. PubMed ID: 17971459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, parallel, single-site pilot trial to compare two different starting doses of methotrexate in methotrexate-naïve adult patients with rheumatoid arthritis.
    Hobl EL; Mader RM; Jilma B; Duhm B; Mustak M; Bröll H; Högger P; Erlacher L
    Clin Ther; 2012 May; 34(5):1195-203. PubMed ID: 22516039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Most rheumatologists are conservative in active rheumatoid arthritis despite methotrexate therapy: results of the PRISME survey.
    Saraux A; Devauchelle-Pensec V; Engerran L; Flipo RM
    J Rheumatol; 2006 Jul; 33(7):1258-65. PubMed ID: 16783865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions of methotrexate use in rheumatoid arthritis by rheumatologists and their patients: an Australian survey study.
    Nash P; Nicholls D
    Int J Rheum Dis; 2013 Dec; 16(6):652-61. PubMed ID: 24382276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of mavrilimumab in Japanese subjects with rheumatoid arthritis: findings from a Phase IIa study.
    Takeuchi T; Tanaka Y; Close D; Godwood A; Wu CY; Saurigny D
    Mod Rheumatol; 2015 Jan; 25(1):21-30. PubMed ID: 24720551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis.
    van Tuyl LH; Plass AM; Lems WF; Voskuyl AE; Kerstens PJ; Dijkmans BA; Boers M
    Rheumatology (Oxford); 2008 Oct; 47(10):1571-6. PubMed ID: 18710900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of serum matrix metalloproteinase-3 as a predictive marker for the long-term disability of rheumatoid arthritis patients in a prospective observational cohort IORRA.
    Shinozaki M; Inoue E; Nakajima A; Hara M; Tomatsu T; Kamatani N; Yamanaka H
    Mod Rheumatol; 2007; 17(5):403-8. PubMed ID: 17929133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional disability can deteriorate despite suppression of disease activity in patients with rheumatoid arthritis: a large observational cohort study.
    Seto Y; Inoue E; Shidara K; Hoshi D; Sugimoto N; Sato E; Tanaka E; Nakajima A; Taniguchi A; Momohara S; Yamanaka H
    Mod Rheumatol; 2013 Nov; 23(6):1179-85. PubMed ID: 23319067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
    Bird P; Griffiths H; Tymms K; Nicholls D; Roberts L; Arnold M; Burnet S; de Jager J; Scott J; Zochling J; Littlejohn G
    J Rheumatol; 2013 Mar; 40(3):228-35. PubMed ID: 23322457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-four-week clinical results of adalimumab therapy in Japanese patients with rheumatoid arthritis: retrospective analysis for the best use of adalimumab in daily practice.
    Kaneko A; Hirano Y; Fujibayashi T; Hattori Y; Terabe K; Kojima T; Ishiguro N
    Mod Rheumatol; 2013 May; 23(3):466-77. PubMed ID: 22895833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, safety, pharmacokinetics and immunogenicity of abatacept administered subcutaneously or intravenously in Japanese patients with rheumatoid arthritis and inadequate response to methotrexate: a Phase II/III, randomized study.
    Iwahashi M; Inoue H; Matsubara T; Tanaka T; Amano K; Kanamono T; Nakano T; Uchimura S; Izumihara T; Yamazaki A; Karyekar CS; Takeuchi T
    Mod Rheumatol; 2014 Nov; 24(6):885-91. PubMed ID: 24708204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A survey on therapy strategies for rheumatoid arthritis in Chinese rheumatologists].
    Wang M; Zhang L; Peng Z; Wang Y; Liu SY
    Zhonghua Nei Ke Za Zhi; 2020 May; 59(5):375-379. PubMed ID: 32370467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of characteristics and therapeutic efficacy in rheumatoid arthritis patients treated by rheumatologists and those treated by orthopedic surgeons under a team medicine approach at the same institute.
    Momohara S; Inoue E; Ikari K; Yano K; Tokita A; Honjo Y; Sakuma Y; Hiroshima R; Iwamoto T; Seto Y; Tanaka E; Taniguchi A; Yamanaka H
    Mod Rheumatol; 2012 Apr; 22(2):209-15. PubMed ID: 21761229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.